Articles
Statistical methods and recent advances in statistical methods for excess risk analysis (2)
Statistical methods and recent advances in statistical methods for excess risk analysis
The course is organized at Corte, Université de Corse (France) from 1st to 05th July 2024. The Corsican Summer School on Modern Methods in Biostatistics and Epidemiology is a crucial event for learning more about statistical methods and recent advances in statistical methods for analysing excess risk. The fourth edition, organized by Professor Roch Giorgi and by the Challenges in the Estimation of Net SURvival (CENSUR) working survival Group.
For more details: http://sesstim.univ-amu.fr/hearstat-2024
The Summer School is aimed at biostatisticians, statisticians, epidemiologists; researchers and students; those working in a registry of cancer, of chronic disease or in any other field relevant to these methodologies and applications.
On YouTube: Presentation on PBCRs' role in cancer control
Updates on ICD-O 3.2 and ICD-O 4
ICD-O-4 (Update as of January 25, 2021)
With the new 5th edition of the Blue Books commencing (it will be completed by mid-2023), it is now the time for the IARC WHO Classification of Tumours Group to start creating new codes. Due to the lack of available codes for new morphological diagnoses in the current 4-digit morphology structure, it is proposed for the next ICD-O edition (ICD-O-4) that a 5th digit will be added.
This approach, with the addition of a “0” where there is no need for a more specific code, or other values if needed was chosen for the ease of conversion and consistency with ICD-O-3 (similar to a MOTNAC to ICD-O-1 conversion). Adding an additional digit to the existing four retains the needed consistency, including the possibility to collapse to previous versions, but will likely require minor changes in registry software, notification forms, etc.
As the previous IACR ICD-O Working Group has now concluded its work with ICD-O-3.2, IACR will establish a new WG with global representation, with a terms of reference that focuses on the required planning for the implementation of ICD-O-4 in cancer registries worldwide.
ICD-O-3.2 (Update as of January 25, 2021):
The preparation of ICD-O-3.2 book (pdf) is at its final stages at the WHO Press, and we hope to have it in the first half of 2021. In the meantime, please refer to the tables available in this page.
Please read through our page on the International Classification of Diseases for Oncology (ICD-O) for details and updates of ICD-O-3.2 and the work that will start for ICD-O-4:
Dr Guillermo Tortolero-Luna
The cancer registry community sympathises with the loved ones left behind by Dr Guillermo Tortolero-Luna, former Director of the Division of Cancer Control and Population Sciences at the University of Puerto Rico Comprehensive Cancer Center and co-director of the Puerto Rico Central Cancer Registry.
Read IARC's message here: https://www.iarc.who.int/fr/news-events/dr-guillermo-tortolero-luna/
Dr Tortolero-Luna actively supported and worked in many international cancer registry activities, including those of the International Association of Cancer Registries (IACR) and the Global Initiative for Cancer Registry Development (GICR). He served as a keynote speaker at IACR's 2018 Scientific Conference in Arequipa, Peru, and shared the experience of the Puerto Rico Central Cancer Registry's transformation into an epidemiologic cancer Surveillance System.
Guidelines on staging of paediatric cancers
New Paediatric Non-Stage Prognosticator Guidelines & an update of 2014 Toronto Stage Guidelines by the International Agency for Research on Cancer (IARC) & partners have been published.
The guidelines were developed by a panel of international experts and stakeholders during a meeting held at IARC, covering the collection of standardized information, which facilitates the interpretation and comparison of data on survival and mortality across regions and over time. The panel also reviewed and updated the 2014 Toronto Paediatric Cancer Stage Guidelines.
Read the article in the Lancet Oncology here: Development of paediatric non-stage prognosticator guidelines for population-based cancer registries and updates to the 2014 Toronto Paediatric Cancer Stage Guidelines
